Microbiota in the gut affect brain physiology via various pathways, and dysbiosis seems to
play a role in the pathogenesis of Parkinson's disease (PD). Probiotics showed pleiotropic …

There is mounting evidence that the microbiota–gut–brain axis (MGBA) is critical in the
pathogenesis and progression of Parkinson's disease (PD), suggesting that probiotic …

A connection between gut microbiota and Parkinson's disease (PD) indicates that dysbiosis
of the gut microbiota might represent a risk factor for PD. Microbiota-targeted interventions …

The gut–brain axis is a hot topic in Parkinson's disease (PD). It has been postulated that gut
pathogens and dysbiosis can contribute to peripheral inflammatory states or trigger …

There is increasing evidence highlighting the potential role of the gut-brain axis in the
pathogenesis of Parkinson's disease (PD) and on the use of probiotics as a therapeutic …

Parkinson's disease (PD) is a prevalent type of neurodegenerative disease. There is
mounting evidence that the gut microbiota is involved in the pathogenesis of PD. Sodium …

Gut microbiota (GM) dysbiosis plays key roles in aggravating Parkinson's disease (PD) and
discovery of agents targeting GM may open new avenues for PD therapy. This study aims to …

Oxidative stress plays a key role in the degeneration of dopaminergic neurons in
Parkinson's disease (PD), which may be aggravated by concomitant PD-associated gut …

Parkinson's disease (PD) patients display alterations in gut microbiota composition.
However, mechanism between gut microbial dysbiosis and pathogenesis of PD remains …

Background Parkinson's disease (PD) is a disease of⍺-synuclein aggregation-mediated
dopaminergic neuronal loss in the substantia nigra pars compacta, which leads to motor and …